Gilead Sciences, Inc.

NEWS

Biotech Bay

Rebound - Gilead Sciences

October 19, 2005

·

5 min read

What Bay Area Executives Made Last Year; Genentech, Gilead

October 19, 2005

·

1 min read

The Day In Review: Positive Coley IPO Not Enough For Biotech

October 19, 2005

·

1 min read

Drug Development

Playing The High-Stakes Biotech Game

October 19, 2005

·

1 min read

BioCapital

What’s Driving Biotech

October 19, 2005

·

1 min read

JOBS

IN THE PRESS

Drug Development

Data From Phase 3 Studies of Gilead Sciences, Inc.'s Sofosbuvir for Hepatitis C in the Forefront

April 23, 2013

·

5 min read

FDA

Gilead Sciences, Inc. Pushes for FDA Blockbuster Approval

April 9, 2013

·

4 min read

Drug Development

Gilead Sciences, Inc. Announces Update on Phase 3 Study of Oral Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients

March 26, 2013

·

1 min read

Biotech Bay

European CHMP Adopts Positive Opinion for Gilead Sciences, Inc.'s Stribild®, a Once-Daily, Integrase Inhibitor-Based, Single Tablet Regimen for the Treatment of HIV-1 Infection

March 22, 2013

·

1 min read

Pharm Country

Cancer Genetics, Inc. Selected by Gilead Sciences, Inc. to Provide Clinical Trial Services for International Trials in Chronic Lymphocytic Leukemia

March 12, 2013

·

2 min read

Drug Development

Gilead Sciences, Inc. Drug Reduces Chest Pain Episodes in Diabetics: Study

March 11, 2013

·

10 min read

Drug Development

Gilead Sciences, Inc. Reveals Full 24-Week Phase 2 Results for HIV Regimen Containing TAF

March 6, 2013

·

13 min read

Drug Development

Gilead Sciences, Inc.-Medivir AB Hepatitis C Drug Clears Virus in Patients

March 4, 2013

·

5 min read

Biotech Bay

Gilead Sciences, Inc. to Present at the Cowen and Company 33rd Annual Health Care Conference on Monday, March 4

March 4, 2013

·

1 min read

Biotech Bay

Gilead Sciences, Inc. to Present at Two Upcoming Investor Conferences

February 26, 2013

·

1 min read